Verified
High Ratings
80+ Specializations
210+ Therapies
Research Phase I/II/III

About Specializations

Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy in Warsaw specializes in nuclear medicine and clinical trials in cancer, heart, lung, and immune diseases.

Medical Center localisation

Ul. Szaserow 128
04-141 Warsaw, Poland

Want to learn more about this study or check if you can participate? Contact us.

Ongoing studies

  • Study on Bendamustine, Rituximab, and Acalabrutinib for Patients with Untreated Mantle Cell Lymphoma

    Not recruiting

    3 1 1
    Belgium Czechia France Germany Greece Hungary +3
  • Study on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    4 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Czechia France Germany Hungary +7
  • Study on the Effectiveness and Safety of Barzolvolimab in Adults with Active Eosinophilic Esophagitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Italy Poland Spain
  • Study of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

    Not recruiting

    2 1 1 1
    France Greece Hungary Italy Poland Spain
  • Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

    Not recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia Denmark Finland +14
  • Study Comparing CT-P53 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Bulgaria Croatia Czechia Poland Romania Spain
  • Study of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Austria France Germany Greece Hungary Ireland +7
  • Study on Dapagliflozin to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    Poland
  • Study of Pembrolizumab and Axitinib Combination Versus Sunitinib for Patients with Advanced or Metastatic Kidney Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Czechia France Germany Hungary Ireland Poland +1
  • Study of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

    Not recruiting

    2 1 1 1
    France Italy Poland Spain